103 related articles for article (PubMed ID: 32034058)
1. Integrated characterisation of cancer genes identifies key molecular biomarkers in stomach adenocarcinoma.
Wang H; Shen L; Li Y; Lv J
J Clin Pathol; 2020 Sep; 73(9):579-586. PubMed ID: 32034058
[TBL] [Abstract][Full Text] [Related]
2. The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid Cancer.
Xu Q; Song A; Xie Q
Technol Cancer Res Treat; 2020; 19():1533033820940440. PubMed ID: 32812852
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations that affect early genetic progression and immune microenvironment in gastric carcinoma.
Li X; Tang Z; Li Z; Li Z; Zhao P; Song Y; Yang K; Xia Z; Wang Y; Guo D
Pathol Res Pract; 2024 May; 257():155310. PubMed ID: 38663178
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive characterization of driver genes in diffuse large B cell lymphoma.
Fan Z; Pei R; Sha K; Chen L; Wang T; Lu Y
Oncol Lett; 2020 Jul; 20(1):382-390. PubMed ID: 32565964
[TBL] [Abstract][Full Text] [Related]
5. MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan-cancer.
Yang Y; Zhang J; Chen Y; Xu R; Zhao Q; Guo W
Clin Transl Med; 2020 Aug; 10(4):e155. PubMed ID: 32898332
[No Abstract] [Full Text] [Related]
6. Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
[TBL] [Abstract][Full Text] [Related]
7. Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer.
Zhao DY; Sun XZ; Yao SK
World J Gastrointest Oncol; 2021 Jan; 13(1):37-57. PubMed ID: 33510848
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a TP53-associated immune prognostic model for gastric cancer.
Nie K; Zheng Z; Wen Y; Shi L; Xu S; Wang X; Zhou Y; Fu B; Li X; Deng Z; Pan J; Jiang X; Jiang K; Yan Y; Zhuang K; Huang W; Liu F; Li P
Genomics; 2020 Nov; 112(6):4788-4795. PubMed ID: 32858135
[TBL] [Abstract][Full Text] [Related]
9. TTN/OBSCN 'Double-Hit' predicts favourable prognosis, 'immune-hot' subtype and potentially better immunotherapeutic efficacy in colorectal cancer.
Liu Z; Wang L; Guo C; Liu L; Jiao D; Sun Z; Wu K; Zhao Y; Han X
J Cell Mol Med; 2021 Apr; 25(7):3239-3251. PubMed ID: 33624434
[TBL] [Abstract][Full Text] [Related]
10. Unique genomic features and prognostic value of COSMIC mutational signature 4 in lung adenocarcinoma and lung squamous cell carcinoma.
Cai X; Chen Z; Deng M; Li Z; Wu Q; Wei J; Dai C; Wang G; Luo C
Ann Transl Med; 2020 Sep; 8(18):1176. PubMed ID: 33241025
[TBL] [Abstract][Full Text] [Related]
11. Noncoding RNAs in gastric cancer: implications for drug resistance.
Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma.
Ye Z; Zheng M; Zeng Y; Wei S; Wang Y; Lin Z; Shu C; Xie Y; Zheng Q; Chen L
Front Genet; 2020; 11():595477. PubMed ID: 33362856
[TBL] [Abstract][Full Text] [Related]
13. muTarget: A platform linking gene expression changes and mutation status in solid tumors.
Nagy Á; Győrffy B
Int J Cancer; 2021 Jan; 148(2):502-511. PubMed ID: 32875562
[TBL] [Abstract][Full Text] [Related]
14.
Mo P; Xie S; Cai W; Ruan J; Du Q; Ye J; Mao J
J Int Med Res; 2020 Sep; 48(9):300060520951405. PubMed ID: 32972288
[TBL] [Abstract][Full Text] [Related]
15. Effect of TTN Mutations on Immune Microenvironment and Efficacy of Immunotherapy in Lung Adenocarcinoma Patients.
Wang Z; Wang C; Lin S; Yu X
Front Oncol; 2021; 11():725292. PubMed ID: 34513703
[TBL] [Abstract][Full Text] [Related]
16. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
[TBL] [Abstract][Full Text] [Related]
17. Cellular Impacts of Striatins and the STRIPAK Complex and Their Roles in the Development and Metastasis in Clinical Cancers (Review).
Li AX; Martin TA; Lane J; Jiang WG
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201504
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy-specific beta-1-glycoprotein 6 is a potential novel diagnostic biomarker of placenta accreta spectrum.
Kashiwagi H; Mariya T; Umemoto M; Ogawa S; Hirohashi Y; Fujibe Y; Kubo T; Someya M; Baba T; Ishioka S; Torigoe T; Saito T
Med Mol Morphol; 2024 Mar; 57(1):35-44. PubMed ID: 37831187
[TBL] [Abstract][Full Text] [Related]
19. Molecular Profile of Variants in
Aguiar KEC; Oliveira IS; Cohen-Paes AN; Coelho RCC; Vinagre LWMS; Rodrigues JCG; Ribeiro-Dos-Santos AM; De Souza SJ; Ribeiro-Dos-Santos Â; Guerreiro JF; Assumpção PP; Santos SEBD; Santos NPCD; Fernandes MR
J Pers Med; 2023 Sep; 13(9):. PubMed ID: 37763132
[TBL] [Abstract][Full Text] [Related]
20. Delta/Notch-like Epidermal Growth Factor-Related Receptor (DNER), a Potential Prognostic Marker of Gastric Cancer Regulates Cell Survival and Cell Cycle Progression.
To HTN; Park JH; Kim JW; Kang D
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
